In brief
Malaysia’s Department of Statistics reported that ischemic heart disease caused 18,001 deaths—13 % of the 199,807 fatalities—in 2025, making it the country’s deadliest illness. The disease’s toll was highest among males and among Malay and Indian populations, while pneumonia led female mortality and among Chinese and other Bumiputera groups. Conflicting reports from BusinessToday Malaysian Facebook and a Bowtie blog present slightly different fatality counts and percentages, underscoring inconsistencies in official data reporting.
Ischemic heart disease (IHD)—a condition where reduced blood flow to the heart muscle leads to tissue death—remains Malaysia’s most lethal health threat, according to the Department of Statistics Malaysia (DOSM). In 2025, IHD caused 18,001 deaths, 13 % of all recorded mortalities, making it the leading cause of death overall.
The disease’s impact was most pronounced among men, who suffered 12,670 IHD deaths, while pneumonia was the top cause for women, claiming 7,684 lives. IHD also dominated fatality rankings among Malays and Indians, whereas Chinese and other Bumiputera communities saw pneumonia at the head of the list.
Overall, Malaysia experienced 199,807 deaths in 2025, a 0.4 percent rise from 198,992 in 2024. DOSM noted that 138,507 deaths, or 69.3 percent, were medically certified, a figure used to calculate disease‑specific mortality percentages.
While DOSM’s figures are often taken as the standard, other reports present diverging numbers. A BusinessToday Malaysia Facebook post lists 18,515 IHD deaths, representing 17.0 percent of medically certified deaths—a higher proportion than DOSM’s 13 percent. Meanwhile, a Bowtie blog post cites 17,421 IHD deaths, again citing a 13.0 percent share of medically certified deaths but offering a lower absolute count.
The discrepancies may stem from differing aggregation methods—DOSM reports total deaths, whereas the BusinessToday post appears to focus on medically certified deaths, and the Bowtie blog may use an alternative dataset or processing threshold. The variations highlight challenges in compiling nationwide mortality statistics and underscore the need for transparent methodology in public health reporting.
These findings are consistent with evidence that IHD remains a functional disease in a country undergoing rapid economic and demographic transitions. Risk factors such as hypertension, diabetes, obesity, and smoking, all of which are rising in Malaysia, likely contribute to the persistent burden of coronary artery disease.
Public health efforts have targeted lifestyle modifications, early diagnosis through electrocardiography and echocardiography, and pharmacologic interventions such as antiplatelet agents and statins. Nonetheless, the high mortality rates suggest that intervention coverage and adherence remain suboptimal, especially among older men and in lower–income ethnic groups.
Given the aging population—projected to have a median age of 42 years by 2030—and ongoing urbanization, Malaysia faces a growing cardiovascular disease burden. WHO estimates predict a 25 percent increase in ischemic heart disease mortality across Southeast Asia by 2030, emphasizing the urgency for coordinated action.
Future mortality surveillance should aim for consistent data collection across all regions and demographic strata, ensuring that policy makers receive accurate, comparable metrics to allocate resources effectively. International collaboration, including data sharing with regional bodies, can help validate national statistics and reconcile apparent mismatches, as the recent divergence between DOSM, BusinessToday, and Bowtie reports illustrate.
